Ascribe
Ascribe is an Ithaca, NY-based agricultural technology company developing natural crop protection solutions. Founded in 2017 based on research from the Boyce Thompson Institute at Cornell University, Ascribe’s flagship biofungicide, Phytalix, harnesses small molecules from the soil microbiome to create effective, environmentally friendly disease control solutions that help farmers grow more resilient crops and harvest higher yields.
Latest News
ABG Update Feature
AgriBusiness Global Report: The Future of Biostimulants: Key Market Trends, Single-Molecule Tech, Grower Adoption
Stephen Pearce, Chairman of Accumont, and Sebastian Bachem, CEO...
Agrochemicals
ADAMA Appoints Dr. Zhigang Hao as President and CEO and Sammy Leibowitz as Chief Financial Officer
Global leadership experience and deep ADAMA expertise to support...
Americas
Cogny Secures Brazil’s First Authorization for Industrial Use of GMOs in Biocontrol Inputs
Historic regulatory approval positions Cogny to advance biotechnology-driven biological...
Industry News
Vylor to Expand Soybean Leadership: Next-Gen Tech Platforms Maintain North America Yield Advantage, Accelerate Latin America Lineup via Broad Spectrum Insect Control
Ahead of its planned separation on October 1, 2026,...